Pharmyn ApS: Financial statements 2017
CVR: 37133892
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
Pharmyn ApS (CVR 37133892) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -3,947 and a net result of DKK -3,947. Equity in the 2017 report amounted to DKK 42,291. The solvency ratio was 87.6%.
- Gross Profit
- DKK -3,947
- Profit/Loss
- DKK -3,947
- Equity
- DKK 42,291
- Total Assets
- DKK 48,291
Keep an eye on Pharmyn ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
Pharmyn ApS has published its interim report for the period October 1, 2015 – December 31, 2016.
About Pharmyn ApS
Pharmyn ApS is a Danish company of the type Anpartsselskab based in Kolding, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Henrik Lund Uth. The company is owned by Henrik Lund Uth. In 2025, the company reported a gross profit of DKK -12,457 and a net result of DKK -12,409 compared with DKK 6,701 the year before. Equity in the 2025 report amounted to DKK 18,662.